Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06693960 · ClinicalTrials.gov registry record · Early Phase 1
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
A Early Phase 1 study of Interaction, sponsored by Washington State University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06693960 is a Early Phase 1 study of Interaction that is actively recruiting participants, run by Washington State University. The registered enrollment target is 16 participants, below the 23-participant average among 3 other Interaction trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06693960, a Early Phase 1 study of Interaction, is actively recruiting participants, sponsored by Washington State University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Oregano
- DRUG Drug cocktail
Study Locations (1)
Washington
- Washington State University College of Pharmacy and Pharmaceutical Sciences - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-09-26 |
| Est. Completion | 2025-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06693960
The ClinicalTrials.gov registry entry for NCT06693960 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 23-participant average among 3 other Interaction trials with a reported enrollment target (30% lower). The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Interaction appearing as the primary indexed condition, and to 2 interventions - of which Oregano is the first listed.
NCT06693960 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06693960 about?
NCT06693960 is a clinical study titled "Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach". The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
What is the current status of trial NCT06693960?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2024-09-26. Estimated completion is 2025-12-31.
What conditions does trial NCT06693960 study?
This clinical trial studies the following conditions: Interaction.
What interventions are being tested in trial NCT06693960?
The interventions under investigation include: Oregano (DIETARY_SUPPLEMENT), Drug cocktail (DRUG).
Who is sponsoring clinical trial NCT06693960?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06693960 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interaction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.